Skip to content

Berad

Active
Private limited company·Activiteiten van medisch specialisten· 19 yrs active
Boeimeerstraat 35 ·2820 Bonheiden, Belgium
BE 0885.730.655
Watch Print / PDF
Age19 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Berad is < 0.1% (very low). The 2025 annual accounts show equity of €1.74M and a net result of €374k. Equity is growing by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 90% of 2192 sector peers (fiscal year 2025). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Trust signals

3 signals
Established
Founded in 2006, 19 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
< 0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Annual accounts: healthy financial profile Long track record

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€374k+56.3%
Working capital€1.74M+19.0%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 16-01-2026 with the NBB · fiscal year 2025 · micro
€0€200k€400k€600kOperating result 2021: €314k€314kNet result 2021: €223k€223kOperating result 2022: €306k€306kNet result 2022: €247k€247kOperating result 2023: €358k€358kNet result 2023: €294k€294kOperating result 2024: €344k€344kNet result 2024: €239k€239kOperating result 2025: €528k€528kNet result 2025: €374k€374k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~3.7%/year over 7 fiscal years, indicative, assuming unchanged policy.
€1.00M€1.50M€2.00M2026: €1.69M (€1.49M - €1.88M)2027: €1.74M (€1.43M - €2.04M)2028: €1.79M (€1.37M - €2.21M)2019: €1.31M2020: €1.47M2021: €1.44M2022: €1.12M2023: €1.31M2024: €1.46M2025: €1.74M2019202020212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 92.6% 58.0%
better than 90% of 2192 sector peers
Net result €374k €60k
better than 95% of 2190 sector peers
Equity €1.74M €74k
better than 95% of 2192 sector peers
Gross operating margin €534k €96k
better than 95% of 2192 sector peers
Total assets €1.88M €186k
better than 95% of 2192 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€529k
+53.3% +163% vs sector
Net profit
€374k
+56.3% +169% vs sector
Cash flow
€375k
+56.1% +160% vs sector
Total assets
€1.88M
+22.5% +98% vs sector
Equity
€1.74M
+19.2% +108% vs sector
Working capital
€1.74M
+19.0% +213% vs sector
Income taxes
€173k
+59.3% +173% vs sector
Dividends
€94k
-0.2% +228% vs sector
Debt
€138k
+88.3% +111% vs sector
Debt ≤ 1y
€138k
+88.3% +111% vs sector
Current ratio
13.56
-35.0% +51% vs sector
Quick ratio
13.56
-35.0% +51% vs sector
Solvency
92.6%
-2.7% +9% vs sector
Debt / equity
0.08
+58.0% +9% vs sector
ROE
21.5%
+31.1% +13% vs sector
ROA
19.9%
+27.6% +42% vs sector
Interest coverage
493.07
+430.6% far above sector median
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€529k
Net profit€374k
Cash flow€375k
Staff costs-
Income taxes€173k
Dividends€94k
Total assets€1.88M
Equity€1.74M
Debt€138k
of which ≤ 1y€138k
of which > 1y-
Working capital€1.74M
Employees (FTE)-
Ratios (computed)
2025
Current ratio13.56
Quick ratio13.56
Working capital ratio92.5%
Solvency92.6%
Debt / equity0.08
Long-term debt ratio-
Interest coverage493.07
Gross margin-
Net margin-
ROA19.9%
ROE21.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€1.88M
Fixed assets 21/28€4k
Tangible fixed assets 22/27€4k
Current assets 29/58€1.87M
Amounts receivable within one year 40/41€0
Investments 50/53€1.43M
Cash & bank 54/58€438k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.88M
Equity 10/15€1.74M
Contributions / capital 10/11€12k
Reserves 13€1.73M
Accumulated profits (losses) 14€0
Amounts payable 17/49€138k
Amounts payable within one year 42/48€138k
Trade debts payable within one year 44€3k
Income statement
Gross operating margin 9900€534k
Operating result 9901€528k
Financial income 75€20k
Financial charges 65€1k
Result before taxes 9903€547k
Income taxes 67/77€173k
Net result for the period 9904€374k
Result to be appropriated 9905€374k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
100 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
BERAD
Boeimeerstraat 35, 2820 BonheidenMedische praktijken
since 20062.261.961.311
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,710 m²
Buildings1
Building footprint235 m²
Volume (LiDAR)1,288 m³
Tallest building6.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12005C0141/00D003 Flanders 2,710 m² 1 · 235 m² 6.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability100
96 / 100

Exceptional profile, strong across almost every axis.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 100

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL Berad
Registered office
Boeimeerstraat 35
2820 Bonheiden, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.